OPTHERION

Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration, dense deposit disease, atypical hemolytic uremic syndrome, and other chronic diseases involving the alternative complement cascade. The company was founded in 2005 and is based in New Haven, Connecticut.

#SimilarOrganizations #People #Financial #Website #More

OPTHERION

Industry:

Biotechnology Health Care Medical

Founded:

2005-01-01

Address:

New Haven, Connecticut, United States

Country:

United States

Website Url:

http://www.optherion.com

Total Employee:

11+

Status:

Active

Contact:

2034920287

Total Funding:

42 M USD

Technology used in webpage:

Viewport Meta Font Awesome Amazon BootstrapCDN Amazon Virginia Region Apache 2.2 NameBright StatCounter OpenSSL 0.9.8 Mod_ssl 2.2.22

Similar Organizations

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

Current Advisors List

david-i-scheer_image

David I. Scheer Chairman of the Board @ Optherion
Board_member

Current Employees Featured

not_available_image

Anil K. Goyal
Anil K. Goyal VP @ Optherion
VP

not_available_image

Gregory Hageman
Gregory Hageman Founder @ Optherion
Founder

Founder

colin-foster_image

Colin Foster

not_available_image

Gregory Hageman

Investors List

johnson-johnson-development-corporation_image

Official Site Inspections

http://www.optherion.com

Host Informations
Whois Informations

Loading ...